Illumina, Inc. (ILMN)
Healthcare • Diagnostics & Research
StockNasdaqGSUnited StatesUS4523271090
209.55 USD
-1.59% today Updated 12 Nov 2026 21:24
Kyvero is an independent information site. It is not affiliated with, endorsed by or sponsored by Illumina, Inc., and has no access to any account you may have with it. The name and the logo belong to their owners.
Price history
Daily prices in USD. Dividends, results and news are marked on the day they happened; click a day to see them.
Updated 12 Nov 2026 21:24. Information, not advice. Showing the last 12 months. Create a free account to see the whole history
Results
Next results
04 Feb 2027
in 83 days · 16:00 · estimate 1.53
Last results
1.44 vs 1.36 estimated
29 Oct 2026 · Beat +6.1%
Beat the estimate
9 of 12
3 missed · 0 in line · 7 beats in a row
Average surprise
+2.7%
reported against the estimate, last 12 quarters
Earnings per share: estimate and reported
Estimate Reported: beat Reported: miss In line
Quarterly results
| Date | EPS estimate | EPS reported | Surprise | Result |
|---|---|---|---|---|
| 04 Feb 2027 16:00 | 1.53 | — | — | Upcoming |
| 29 Oct 2026 16:00 | 1.36 | 1.44 | +6.1% | Beat |
| 30 Jul 2026 16:00 | 1.23 | 1.31 | +6.8% | Beat |
| 30 Apr 2026 16:00 | 1.06 | 1.15 | +9.0% | Beat |
| 05 Feb 2026 16:00 | 1.23 | 1.35 | +9.7% | Beat |
| 30 Oct 2025 16:00 | 1.17 | 1.34 | +14.7% | Beat |
| 31 Jul 2025 16:00 | 1.01 | 1.19 | +17.7% | Beat |
| 08 May 2025 16:00 | 0.94 | 0.97 | +3.3% | Beat |
| 06 Feb 2025 16:00 | 0.92 | 0.86 | -6.8% | Miss |
| 04 Nov 2024 16:00 | 0.88 | 1.14 | +29.0% | Beat |
| 06 Aug 2024 16:00 | 0.90 | 0.36 | -60.0% | Miss |
| 02 May 2024 16:00 | 0.11 | 0.09 | -15.1% | Miss |
| 08 Feb 2024 16:00 | 0.12 | 0.14 | +17.6% | Beat |
| 09 Nov 2023 16:00 | 0.14 | 0.33 | +135.1% | Beat |
| 09 Aug 2023 16:00 | 0.02 | 0.32 | +1,326.0% | Beat |
| 25 Apr 2023 16:00 | 0.03 | 0.08 | +198.2% | Beat |
| 07 Feb 2023 16:00 | 0.19 | 0.14 | -24.8% | Miss |
| 03 Nov 2022 16:00 | 0.30 | 0.34 | +13.2% | Beat |
| 11 Aug 2022 16:00 | 0.64 | 0.57 | -11.6% | Miss |
| 05 May 2022 16:00 | 0.89 | 1.07 | +20.8% | Beat |
| 10 Feb 2022 16:00 | 0.49 | 0.75 | +54.5% | Beat |
| 04 Nov 2021 16:00 | 1.22 | 1.45 | +19.1% | Beat |
| 05 Aug 2021 16:00 | 1.36 | 1.87 | +37.1% | Beat |
| 27 Apr 2021 16:00 | 1.40 | 1.89 | +35.1% | Beat |
| 11 Feb 2021 16:00 | 1.13 | 1.22 | +7.9% | Beat |
| 29 Oct 2020 16:00 | 0.80 | 1.02 | +26.9% | Beat |
| 06 Aug 2020 16:00 | 0.67 | 0.62 | -7.4% | Miss |
| 30 Apr 2020 17:00 | 1.25 | 1.64 | +31.2% | Beat |
| 29 Jan 2020 16:00 | 1.58 | 1.70 | +7.4% | Beat |
| 24 Oct 2019 16:00 | 1.41 | 1.93 | +37.3% | Beat |
| 29 Jul 2019 16:00 | 1.34 | 1.35 | +1.1% | Beat |
| 25 Apr 2019 16:00 | 1.35 | 1.60 | +18.6% | Beat |
| 29 Jan 2019 16:00 | 1.36 | 1.32 | -2.8% | Miss |
| 23 Oct 2018 16:00 | 1.26 | 1.52 | +20.7% | Beat |
| 30 Jul 2018 16:00 | 1.11 | 1.43 | +28.6% | Beat |
| 24 Apr 2018 16:00 | 1.02 | 1.45 | +42.5% | Beat |
| 30 Jan 2018 16:00 | 1.21 | 1.44 | +18.8% | Beat |
| 24 Oct 2017 16:00 | 0.99 | 1.11 | +11.6% | Beat |
| 01 Aug 2017 16:00 | 0.69 | 0.82 | +19.6% | Beat |
| 25 Apr 2017 16:00 | 0.64 | 0.64 | -0.7% | In line |
| 31 Jan 2017 16:00 | 0.83 | 0.85 | +2.5% | Beat |
| 01 Nov 2016 16:00 | 0.87 | 0.97 | +11.6% | Beat |
| 26 Jul 2016 16:00 | 0.73 | 0.86 | +17.4% | Beat |
| 03 May 2016 16:00 | 0.74 | 0.71 | -4.0% | Miss |
| 02 Feb 2016 16:00 | 0.82 | 0.81 | -1.1% | Miss |
| 20 Oct 2015 16:00 | 0.79 | 0.80 | +1.9% | Beat |
| 21 Jul 2015 16:00 | 0.77 | 0.80 | +3.4% | Beat |
| 21 Apr 2015 16:00 | 0.72 | 0.91 | +26.3% | Beat |
| 27 Jan 2015 16:00 | 0.78 | 0.87 | +11.1% | Beat |
| 20 Oct 2014 16:00 | 0.56 | 0.77 | +38.0% | Beat |
Annual results · USD
| Year | Revenue | Change | Net income | Net margin | EPS | EPS change | Free cash flow |
|---|---|---|---|---|---|---|---|
| 2025 | 4.3B | -0.7% | 850M | 19.6% | 5.45 | +170.9% | 931M |
| 2024 | 4.4B | -2.9% | -1.2B | -28.0% | -7.69 | -4.8% | 709M |
| 2023 | 4.5B | -1.7% | -1.2B | -25.8% | -7.34 | +73.8% | 283M |
| 2022 | 4.6B | — | -4.4B | -96.1% | -28.00 | — | 106M |
Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.
Prices by day, week and month
| Period | Opening price | High | Low | Closing price | Change | Volume | Dividend |
|---|---|---|---|---|---|---|---|
| 09 Nov 2026 – 12 Nov 2026 In progress | 216.98 | 227.71 | 197.81 | 209.55 | -1.68% | 6,790,912 | |
| 02 Nov 2026 – 06 Nov 2026 | 236.01 | 244.05 | 205.00 | 213.13 | -9.69% | 14,492,000 | |
| 26 Oct 2026 – 30 Oct 2026 | 269.69 | 294.21 | 231.18 | 235.99 | -12.41% | 12,766,600 | |
| 19 Oct 2026 – 23 Oct 2026 | 268.93 | 286.40 | 257.31 | 269.42 | +2.62% | 9,244,500 | |
| 12 Oct 2026 – 16 Oct 2026 | 277.60 | 278.00 | 257.14 | 262.54 | -5.62% | 11,135,000 | |
| 05 Oct 2026 – 09 Oct 2026 | 273.00 | 309.35 | 254.00 | 278.17 | +1.88% | 16,617,000 | |
| 28 Sep 2026 – 02 Oct 2026 | 265.95 | 280.17 | 262.89 | 273.04 | +1.13% | 12,934,000 | |
| 21 Sep 2026 – 25 Sep 2026 | 241.51 | 277.95 | 234.57 | 270.00 | +12.68% | 16,639,600 | |
| 14 Sep 2026 – 18 Sep 2026 | 206.74 | 250.06 | 202.82 | 239.62 | +16.07% | 44,841,900 | |
| 08 Sep 2026 – 11 Sep 2026 | 218.65 | 219.45 | 200.01 | 206.45 | -5.39% | 7,233,800 | |
| 253 older periods: create a free account to see the whole history | |||||||
Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.
News
- Is Illumina Stock Worth The Wait? (opens in a new tab) Trefis · 11 Nov 2026 15:29
- Global Biotechnology Market to Reach $5 Trillion by 2032, Driven by Biopharmaceuticals, Gene Editing and Sustainable Innovation | Features Profiles of Danaher, Roche, Illumina, Merck, Thermo Fisher and More (opens in a new tab) 11 Nov 2026 14:44
- Carrier Screening - Global Strategic Business Report 2026: Secure Your Share of a $7.6 Billion Market by 2032 | Features Competitive Intelligence on Illumina, Natera, BGI Genomics, and Myriad Genetics (opens in a new tab) 11 Nov 2026 14:25
- Whole Exome Sequencing - Global Strategic Business Report 2026: Capitalize on 19.5% CAGR to $2.3 Billion by 2032 as Illumina, Thermo Fisher Scientific, BGI Genomics, and QIAGEN Accelerate (opens in a new tab) 11 Nov 2026 14:20
- Single-Cell Analysis - Global Strategic Business Report 2026: Capitalize on 20.4% CAGR as Illumina, Thermo Fisher Scientific, Bio-Rad and Agilent Battle for Shares in the $26.1 Billion Market by 2032 (opens in a new tab) 11 Nov 2026 14:18
- Human Identification - Global Strategic Business Report 2026: Capitalize on 10.1% CAGR to $1.9 Billion by 2032 | Thermo Fisher, Illumina, Qiagen and Bio-Rad Vie for Shares (opens in a new tab) 11 Nov 2026 14:15
- Genomics - Global Strategic Business Report 2026: Capitalize on the $117.3 Billion Market by 2032, Featuring Strategic Intelligence on Illumina, Thermo Fisher Scientific, Danaher, and Oxford Nanopore (opens in a new tab) 11 Nov 2026 14:14
- Molecular Cytogenetics - Global Strategic Business Report: Capitalize on 8.8% CAGR to US$3.5 Billion by 2030; Outmaneuver Abbott, Agilent, Bio-Rad, Illumina and Roche Amid Tariff Shifts (opens in a new tab) 11 Nov 2026 14:13
- Epigenetics - Global Strategic Business Report: Capitalize on an 18.2% CAGR to Secure the $5.5 Billion 2030 Market as Illumina, Thermo Fisher Scientific, Qiagen, and Bio-Rad Disrupt Precision Medicine (opens in a new tab) 11 Nov 2026 14:12
- Missed Illumina's 76% Run? Here Is What Holders Saw (opens in a new tab) Simply Wall St. · 11 Nov 2026 09:12
- How Investors May Respond To Illumina (ILMN) Earnings Beat (opens in a new tab) Simply Wall St. · 11 Nov 2026 08:11
- Illumina (ILMN) Unveils Duplex Sequencing Workflow For MRD Research (opens in a new tab) Simply Wall St. · 11 Nov 2026 07:10
- Illumina Bets on Clinical Demand for Growth as Research Funding Uncertainty Persists (opens in a new tab) MarketBeat · 11 Nov 2026 00:14
- Illumina, Inc. (ILMN) Presents at 2026 UBS Global Healthcare Conference Transcript (opens in a new tab) SeekingAlpha · 10 Nov 2026 15:31
- Nucleic Acid Isolation and Purification - Global Strategic Business Report: Capture the $3.9 Billion Revenue Surge by 2030 as Thermo Fisher, Qiagen, Danaher, Illumina, and Bio-Rad Battle for Share (opens in a new tab) 10 Nov 2026 15:02
Headlines link to the original articles of the publishers shown; Kyvero does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.
Key data
- Previous close
- 212.93 USD
- Market cap
- 31.9B
- Exchange
- NasdaqGS
- Country
- United States
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Currency
- USD
Dividends
No dividends on record.
Why this score
Similar shares
Follow ILMN and get alerts
Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.